DoktorABC

A pure intermediary that expressly disclaims being a pharmacy. It sells a Fernbehandlungsgutschein and an RX-Gutschein plus a Servicegebühr in its own name; the medicine sale is between the patient and a Dutch partner pharmacy, and the treatment contract is with a Kooperationsarzt. Questionnaire, self-declared BMI, asynchronous review, payment before the doctor looks. Dispensing via Helix Pharmacy B.V. (KvK 84408871) from Belfeld, Netherlands. Prescribers include Hasan and Ela Igde in Berlin plus a panel from Croatia, Norway and Portugal. Photo ID required at the door. No app.

Germany: Mounjaro €235.80 (2.5 mg) to €519.01 (15 mg), which is the German Apothekenverkaufspreis plus exactly €29.00 on every SKU, plus a €49 Behandlungsgebühr. Total €284.80 for a first month against Zava’s €240.79, a constant €44.01 more at every dose, of which €29 is hidden inside the medicine line.

None disclosed anywhere. No rounds, no investors, no valuation, no revenue estimate. Unaudited abridged accounts disclose no turnover. Survived a First Gazette compulsory strike-off notice by eight days in September 2025.

Trustpilot 4.7 on 49,833 reviews, marginally larger than Zava Germany at 48,380, but zero of the reviews in the live payload mention a GLP-1 and fourteen mention cannabis. Weight loss is 1.7 per cent of a 5,226-URL German estate. Medical cannabis is the first category card on the homepage.

Never sued, abgemahnt or sanctioned by anyone, anywhere, after nine years of trading. That is a verified negative across German courts, the Apothekerkammern, Wettbewerbszentrale, VSW, the Dutch IGJ, the ASA and the MHRA. Read it as latency: the model matches four 2025 German decisions feature for feature, and the Apothekerkammer Nordrhein took its closest structural analogue, Apomeds, from an HWG injunction to two default judgments and liquidation inside twelve months.

The live site carries a false pricing claim (billing only after doctor approval, contradicted by AGB 7.3 and 8.1), a competitor pharmacy’s KvK number in its own statutory Impressum, two abandoned corporate addresses, no responsible physician, and a funnel host that defaults all six consent categories to granted and fires the Meta Pixel before any consent interface.

Sky Marketing Ltd files unaudited abridged accounts, which disclose no turnover and no profit-and-loss detail. It has never filed a figure from which German revenue could be derived. Crunchbase, Dealroom, Tracxn and PitchBook all show no funding rounds, no investors, no valuation and no revenue estimate. Dealroom lists the headcount as two to ten people, which is implausible for the evident scale of the operation. The company that sells GLP-1s to more German consumers than almost anyone else has GBP 1 of issued capital and discloses nothing.

Helix Pharmacy B.V. has filed balance sheets for FY2022 through FY2025 with the Dutch Handelsregister. Dutch small-company deposits are balance-sheet only with no profit and loss, and Helix serves at least one unrelated German webshop, so the figure would be contaminated. It is nonetheless the closest available window on DoktorABC’s German dispensing volume and it is purchasable for a small sum.

Two places, and only one of them is disclosed. The stated Behandlungsgebühr is 49 EUR on the Mounjaro page. On top of that, every medicine is sold at the German Apothekenverkaufspreis plus exactly 29,00 EUR. That second margin is not presented as a fee at all; it is inside the number the customer reads as the price of the drug. On a first month of Mounjaro 2.5 mg the disclosed fee is 49 EUR and the undisclosed one is 29 EUR, so more than a third of DoktorABC’s take is invisible.

Four different figures appear across sources, all plausibly correct at different moments: 49 EUR on the current Mounjaro page, 30 EUR in April 2025 halved as an Easter promotion, a range of 7 EUR to 110 EUR across treatment categories with 99 EUR for a video consultation, and 1 EUR with a promotional code. A discount code was running live when these screenshots were taken. Anyone modelling DoktorABC’s economics on a single fee number will be wrong. The 29 EUR drug markup, by contrast, looks stable and never moves.

Germany has 42 indexed brand-named or molecule-named URLs against Zava’s 43. To within one URL the two German volume leaders are running the identical naming strategy at the identical scale. But DoktorABC goes further on the page itself: the drug is named in the title and the H1, the verb is "Kaufen", there is a full dose-by-dose price ladder, published PZN codes, and a live "auf Lager" stock indicator, all on an indexed page reachable with no interaction whatsoever.

Exhaustive string search of the raw HTML of the homepage, the Mounjaro, Wegovy, Ozempic and Saxenda pages and both weight-loss category pages returns zero occurrences of Heilmittelwerbegesetz, zero of HWG, zero of Werbeverbot, zero of Pflichtangaben, zero of Pflichttext and zero of the standard German Zu Risiken und Nebenwirkungen formula. Not one marker on any page.

Zava’s obvious German category URL is a noindex empty shell outside the sitemap, so a shallow check wrongly concludes compliance. DoktorABC has no such artefact. It emits no robots meta tag and no canonical on any product or category page, so everything defaults to index,follow, and every commercially important weight-loss page is server-rendered, indexable and in the sitemap. The Mounjaro page is 63KB of HTML naming the drug 165 times before a line of JavaScript executes.

This is the sharpest finding in the dossier. The category page states in the benefit list directly under the primary call to action that billing happens only after the doctor approves, and that costs arise only once the doctor has approved the treatment. The binding terms say the reverse, twice. AGB clause 7.3: all fees are due on conclusion of contract and payable in advance. AGB clause 8.1: the teleconsultation cannot begin and the medicine cannot be delivered until the fees have been received in full. The service-limitations page confirms the sequence in the company’s own words: the patient registers, enters the delivery address, confirms the order and pays, and only once the order has been submitted is the questionnaire reviewed by one of the doctors. The money is captured first and refunded if declined, which is precisely what the marketing claim denies.

The category page advertises a Behandlungsgebühr of 29 EUR while every product page says 49 EUR, and advertises a medicine from 44,99 EUR when the cheapest weight-loss medicine on the site is 92,93 EUR. The weight-loss category is entirely absent from the published fee schedule that the AGB itself designates as authoritative.

The funnel bundle contains a bmi_question type with client-side validation driven by user-entered height and weight, and the public site runs a free-standing BMI calculator that feeds straight into the funnel. Photo and document upload machinery exists in the bundle but is associated with other categories. No mandatory photographic or documentary weight evidence was found in the weight-loss flow. Zava Germany requires uploaded photographs. This is a materially lower clinical bar, though it could not be confirmed from inside the funnel.

To accept delivery the patient must present a valid official photo identity document, a passport or driving licence, to the courier. That is a real control, and it is applied at the doorstep rather than at registration, which means it catches diversion but does nothing to improve the quality of the clinical decision made days earlier.

6,142 URLs across five markets, of which 5,226 are German. Weight loss is 1.7 per cent of the German estate. On the live homepage the first category card is medical cannabis, then erectile dysfunction, then Übergewicht. This matters commercially: DoktorABC is not a focused GLP-1 competitor, it is a broad-line pharmacy intermediary whose GLP-1 line rides on cannabis-funded logistics.

Verified live. It gives the Geschäftssitz as 4th Floor, 39 Dover Street, London W1S 4NN, an address the company left in 2025, while the footer of the same page gives Office 219 LABS Atrium, Stables Market, Chalk Farm Road NW1 8AH, which it left in May 2026. Neither is the current registered office. It names Helix Pharmacy B.V. against Handelsregisternummer 81205864, which is Prime Pharmacy’s number, not Helix’s. And it names no responsible physician at all. Any one of those is a citable §5 DDG or §5a UWG defect.

Google Tag Manager proxied first-party through a /metrics/ path with gtm_region_override set to US on a German audience, three GA4 properties, legacy Universal Analytics, three Google Ads accounts, Meta, Bing, Reddit, Snapchat, AdRoll and DoubleClick. The consent banner is hand-rolled and is suppressed entirely for logged-in customers. Most seriously, the funnel host, which handles the clinical questionnaire and the payment, contains an inline script before anything else in the head that defaults all six Google consent categories to granted when no prior choice is stored, and then fires the Meta Pixel with a custom event before any consent interface appears. Pre-consent advertising storage on a German health property is difficult to defend under Article 6 GDPR and §25 TDDDG.

Including phpmyadmin.internal, argocd.internal and kibana.internal. There are no AI crawler directives anywhere in robots.txt, the same omission as Zava.

doktorabc.net is a third-party affiliate running brand-named GLP-1 content through a tracking redirector, which is a referral-liability surface of exactly the kind the ASA punished Zava for in February 2026. Meanwhile there are zero named-competitor comparison pages across all 6,142 URLs, precisely mirroring Zava. Both German volume leaders have left the entire Anbieter Vergleich search results page to affiliates.

Despite a subscription Care Plan and an inherently repeat-purchase book. The same structural retention gap as Zava.

Trustpilot shows 4.7 on 49,833 reviews, with a one-star rate of 3.56 per cent, read from the raw payload rather than rendered text. But across the 53 review objects in the live payload, delivery terms appear 49 times, cannabis terms 14 times, and GLP-1 or weight-loss terms zero times. Trustpilot’s own AI summary of 34,031 German reviews discusses packaging in tins versus mailer bags, and strains being temporarily unavailable. Its product topic summary praises the selection and the effective flower. Benchmarking that 4.7 against Zava’s 4.8 compares two different businesses.

A second Trustpilot profile at doktorabc.com/de shows 2.1 on 130 reviews. Trustpilot’s own competitive module surfaces it. Anyone landing on the German-path profile records DoktorABC at 2.1 stars. Zava has an identical trap, a near-empty UK profile at 3.2 on three reviews. Both German volume leaders have a duplicate profile that misreports them by two full stars.

Two agents reached different numbers. Direct reading of the live Trustpilot payload gives 49,833 reviews. The corporate agent, blocked by Trustpilot on every locale, worked from indexed pagination and reached only 27,000 to 33,300, and proposed that our figure was a conflation of Trustpilot with the separate Trusted Shops profile at 20,279 reviews and 4.78. The direct payload read is the better evidence and 49,833 stands, but the Trusted Shops estate is real and separate and worth knowing about.

Zava Germany 4.8 on 48,380, DoktorABC 4.7 on 49,833. The next largest German player Trustpilot surfaces, DrAnsay, is an order of magnitude smaller at 3,250. These two are the German market, and one of them is not really in the weight-loss business.